CORRECTED-UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21)

April 21 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month, ahead of an expected U.S. launch in the second half of 2017.